{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:50:36Z","timestamp":1791895836836,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019771","name":"European Commission Seventh Framework Programme for Research and Technological Development","doi-asserted-by":"publisher","award":["HEALTH-F2-2010-242114"],"award-info":[{"award-number":["HEALTH-F2-2010-242114"]}],"id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.schres.2026.08.022","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:21:34Z","timestamp":1787919694000},"page":"254-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Baseline inflammatory profile is associated with short-term antipsychotic-induced weight gain in first-episode psychosis: results from the OPTiMiSE study"],"prefix":"10.1016","volume":"297","author":[{"given":"Daphne A.M.","family":"Dielemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Huizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"van der Pluijm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Thijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico J.M.","family":"van Beveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieuwe","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.schres.2026.08.022_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13216394","article-title":"Immunology of Stress: A Review Article","volume":"13","author":"Alotiby","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.schres.2026.08.022_bb0010","article-title":"Baseline levels of C-reactive protein and proinflammatory cytokines are not associated with early response to amisulpride in patients with first episode psychosis: the OPTiMiSE cohort study","volume":"2","author":"Barbosa","year":"2021","journal-title":"Schizophr. B. Open"},{"key":"10.1016\/j.schres.2026.08.022_bb0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbi.2020.04.039","article-title":"Altered peripheral blood compounds in drug-naive first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis","volume":"88","author":"Cakici","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.schres.2026.08.022_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2026.08.022_bb0025","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1007\/s12035-016-0309-1","article-title":"Functional Implications of the IL-23\/IL-17 Immune Axis in Schizophrenia","volume":"54","author":"Debnath","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"1-3","key":"10.1016\/j.schres.2026.08.022_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2013.10.019","article-title":"Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway","volume":"151","author":"Dimitrov","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.08.022_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/513948","article-title":"Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review","volume":"2010","author":"Fain","year":"2010","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.schres.2026.08.022_bb0040","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1192\/j.eurpsy.2023.2417","article-title":"Predicting antipsychotic-induced weight gain in first episode psychosis - a field-wide systematic review and meta-analysis of non-genetic prognostic factors","volume":"66","author":"Fitzgerald","year":"2023","journal-title":"Eur. Psychiatry."},{"key":"10.1016\/j.schres.2026.08.022_bb0045","article-title":"Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort","volume":"22","author":"Foiselle","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"issue":"1","key":"10.1016\/j.schres.2026.08.022_bb0050","first-page":"1","article-title":"Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications","volume":"2","author":"Fonseka","year":"2016","journal-title":"Mol Neuropsychiatry"},{"key":"10.1016\/j.schres.2026.08.022_bb0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-immunol-032713-120236","article-title":"Metabolic regulation of immune responses","volume":"32","author":"Ganeshan","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.schres.2026.08.022_bb0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-clinpsy-081122-013201","article-title":"Immune Dysfunction in Schizophrenia Spectrum Disorders","volume":"20","author":"Gangadin","year":"2024","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"6","key":"10.1016\/j.schres.2026.08.022_bb0065","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jpsychires.2008.11.001","article-title":"Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course","volume":"43","author":"Gebhardt","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.schres.2026.08.022_bb0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1467-789X.2009.00589.x","article-title":"Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications","volume":"10","author":"Gentile","year":"2009","journal-title":"Obes. Rev."},{"issue":"4","key":"10.1016\/j.schres.2026.08.022_bb0075","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11336-021-09773-2","article-title":"A Guide for Sparse PCA: Model Comparison and Applications","volume":"86","author":"Guerra-Urzola","year":"2021","journal-title":"Psychometrika"},{"issue":"5","key":"10.1016\/j.schres.2026.08.022_bb0080","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/s41380-022-01494-x","article-title":"Schizophrenia: a disorder of broken brain bioenergetics","volume":"27","author":"Henkel","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"10202","key":"10.1016\/j.schres.2026.08.022_bb0085","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.schres.2026.08.022_bb0090","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(18)30252-9","article-title":"Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study","volume":"5","author":"Kahn","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.08.022_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamapsychiatry.2015.2872","article-title":"Dopamine, Striatum, Antipsychotics, and Questions About Weight Gain","volume":"73","author":"Kapur","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.08.022_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.08.022_bb0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbi.2020.07.043","article-title":"Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum","volume":"91","author":"Lago","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2026.08.022_bb0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/ITT.S262566","article-title":"GM-CSF: a promising target in inflammation and autoimmunity","volume":"9","author":"Lee","year":"2020","journal-title":"Immunotargets Ther."},{"issue":"3","key":"10.1016\/j.schres.2026.08.022_bb0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/mp.2011.109","article-title":"Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications","volume":"17","author":"Lett","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.08.022_bb0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbv019","article-title":"The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics","volume":"41","author":"Leucht","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2026.08.022_bb0125","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2026.08.022_bb0130","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1586\/ern.10.85","article-title":"Management of antipsychotic-related weight gain","volume":"10","author":"Maayan","year":"2010","journal-title":"Expert. Rev. Neurother."},{"issue":"1","key":"10.1016\/j.schres.2026.08.022_bb0135","article-title":"Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study","volume":"9","author":"Martinuzzi","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2026.08.022_bb0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.08.022_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamapsychiatry.2015.2582","article-title":"Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment","volume":"73","author":"Nielsen","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.08.022_bb0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/acps.13074","article-title":"Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort)","volume":"140","author":"Pandit","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.schres.2026.08.022_bb0155","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/sms.12983","article-title":"Serum IL-15 and IL-15Ralpha levels are decreased in lean and obese physically active humans","volume":"28","author":"Perez-Lopez","year":"2018","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"10.1016\/j.schres.2026.08.022_bb0160","first-page":"217","article-title":"Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers","volume":"5","author":"Petrescu","year":"2010","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.schres.2026.08.022_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.08.022_bb0170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.08.022_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113101","article-title":"Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia","volume":"402","author":"Prestwood","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.schres.2026.08.022_bb0180","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1152\/ajpendo.90506.2008","article-title":"Oversecretion of interleukin-15 from skeletal muscle reduces adiposity","volume":"296","author":"Quinn","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.schres.2026.08.022_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1346317","article-title":"Interleukin-16 is increased in obesity and alters adipogenesis and inflammation in vitro","volume":"15","author":"Reyes-Farias","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.schres.2026.08.022_bb0190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/CIRCRESAHA.108.177105","article-title":"Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity","volume":"103","author":"Rocha","year":"2008","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.schres.2026.08.022_bb0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tem.2012.05.011","article-title":"Adipose tissue-resident immune cells: key players in immunometabolism","volume":"23","author":"Schipper","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.schres.2026.08.022_bb0200","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.20110278","article-title":"HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.schres.2026.08.022_bb0205","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2174\/1570159X15666170630163616","article-title":"Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects","volume":"16","author":"Siafis","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.schres.2026.08.022_bb0210","doi-asserted-by":"crossref","DOI":"10.1007\/s12170-025-00762-z","article-title":"Antipsychotic-induced weight gain: what have we learned?","volume":"19","author":"Silas","year":"2025","journal-title":"Curr. Cardiovasc. Risk Rep."},{"key":"10.1016\/j.schres.2026.08.022_bb0215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2018.12.003","article-title":"Antipsychotics-induced metabolic alterations: Recounting the mechanistic insights, therapeutic targets and pharmacological alternatives","volume":"844","author":"Singh","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2026.08.022_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12991-020-00294-3","article-title":"Correction to: the impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey","volume":"19","author":"Tandon","year":"2020","journal-title":"Ann. General Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.08.022_bb0225","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/jimmun\/vkae064","article-title":"IL-7Ralpha signaling in regulatory T cells of adipose tissue is essential for systemic glucose homeostasis","volume":"214","author":"Tani-Ichi","year":"2025","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.schres.2026.08.022_bb0230","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/0269881120907972","article-title":"A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)","volume":"34","author":"Ter Hark","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.schres.2026.08.022_bb0235","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/intimm\/dxt018","article-title":"Linking the microbiota and metabolic disease with lymphotoxin","volume":"25","author":"Upadhyay","year":"2013","journal-title":"Int. Immunol."},{"issue":"8","key":"10.1016\/j.schres.2026.08.022_bb0240","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1038\/tp.2014.52","article-title":"Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia","volume":"4","author":"van Beveren","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.08.022_bb0245","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","article-title":"Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development","volume":"36","author":"van der Windt","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.schres.2026.08.022_bb0250","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mito.2021.10.009","article-title":"Role of GM-CSF in regulating metabolism and mitochondrial functions critical to macrophage proliferation","volume":"62","author":"Wessendarp","year":"2022","journal-title":"Mitochondrion"},{"issue":"8","key":"10.1016\/j.schres.2026.08.022_bb0255","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm.2001","article-title":"Normalization of obesity-associated insulin resistance through immunotherapy","volume":"15","author":"Winer","year":"2009","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.schres.2026.08.022_bb0260","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood-2007-06-096297","article-title":"IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival","volume":"111","author":"Wofford","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.schres.2026.08.022_bb0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14205\/2312-3710.2014.01.01.3","article-title":"Mechanisms of Increased Appetite and Weight Gain Induced by Psychotropic Medications","volume":"1","author":"Wysoki\u0144ski","year":"2014","journal-title":"Journal of Advanced Clinical Pharmacology"},{"issue":"6","key":"10.1016\/j.schres.2026.08.022_bb0270","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1161\/STROKEAHA.115.007984","article-title":"What is missing from my missing data plan?","volume":"46","author":"Yeatts","year":"2015","journal-title":"Stroke"},{"issue":"22","key":"10.1016\/j.schres.2026.08.022_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/cells11223554","article-title":"Advances in T Cells Based on Inflammation in Metabolic Diseases","volume":"11","author":"Yu","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.schres.2026.08.022_bb0280","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.4049\/jimmunol.1001269","article-title":"IL-17 regulates adipogenesis, glucose homeostasis, and obesity","volume":"185","author":"Zuniga","year":"2010","journal-title":"J. Immunol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:11:42Z","timestamp":1791893502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426002720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S0920996426002720"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.08.022","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline inflammatory profile is associated with short-term antipsychotic-induced weight gain in first-episode psychosis: results from the OPTiMiSE study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}